Collaborations search results
12 Results for ''
-
Brain Targeted Therapeutic Collaboration
Combine our shuttles with your drugs to create new brain targeted therapeutics for patients. -
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Bridging the Funding Gap for Brain Therapeutics
A unique opportunity to help develop a new generation of brain targeted drugs -
Brigham-Wyss DxA
The Wyss DxA's clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests. -
Biomarker Discovery Laboratory (BDL)
Bridging the diagnostic gap from biomarker discovery to market-ready test kits and instruments through cutting-edge technology development and clinical collaboration. -
Collaborative Fund Venture Alliance
Our alliance with Collab Fund supports sustainable materials to fight climate change. -
Giving at the Wyss
The generous support of donors enables us to harness the creative power of Harvard scientists, engineers, and clinicians to create breakthrough bioinspired technologies that address global challenges in healthcare and the environment. However, these discoveries can’t change the world if they don’t leave the lab. Your gift will help us continue to generate an unprecedented... -
Wyss DxA Industrial Participant Program
As the industry-facing component of the Wyss Diagnostics Accelerator, the Industrial Participant Program is a collaboration hub between healthcare testing companies and the scientific and clinical community within the Wyss ecosystem that seeks to compress the timeframe for bringing new, high-impact, diagnostic technologies to market. -
Wyss Brain Targeting Program
Advancing brain delivery approaches that enable more safe and effective brain-targeted therapeutics. -
Wyss Diagnostics Accelerator (DxA)
An initiative to enable the fast creation of diagnostic technologies to solve high-value clinical problems through deep collaborations driven by unmet diagnostic needs. -
Northpond Labs Alliance
Our alliance with Northpond Labs supports early-stage, transformative research with strong translational potential as part of a collaborative Laboratory for Bioengineering Research Innovation. -
i3 Center: Biomaterials to Create T Cell Immunity
Cancer immunologists and biological engineers are developing new biomaterials-based approaches to develop new anti-cancer immunotherapies for treatment-resistant cancers.